Sitemap
Partners
Investors
Careers
News
AL
EN
Home
About Us
Cure Technology / Healing Philosophy
Overview
Company Profile
Leadership
History
Calendar
Current events
Archives
Products
Focused On Your Health
Product Categories
New Products
Product Development
Operations
Where Health Meets Chemistry
Manufacturing
Quality Assurance
Quality Control
Generics Development
Regulatory Affairs
Production Lines
Inspection
Logistics
New Investments
News & Media
Research And Dedication
News & Events
Multimedia Gallery
Publications
Blog
Our Caring
Another Level Of Care
Protect our People
Our Giving
Company Initiatives
Get in Touch
Digital Address
Reporting side effects
Menu:
Home
About Us
— About Us
—— Overview
—— Company Profile
—— Leadership
—— History
—— Calendar
——— Current events
——— Archives
Products
— Products
—— Product Categories
—— New Products
—— Product Development
Operations
— Operations
—— Manufacturing
——— Quality Assurance
——— Quality Control
——— Generics Development
——— Regulatory Affairs
——— Production Lines
——— Inspection
—— Logistics
—— New Investments
News & Media
— News & Media
—— News & Events
—— Multimedia Gallery
—— Publications
—— Blog
Our Caring
— Our Caring
—— Protect our People
—— Our Giving
—— Company Initiatives
Get in Touch
— Digital Address
— Reporting side effects
Avacyn
ATC Classification System:
Antiinfectives For Systemic Use
Current Status of Product Registration:
Albania
OTC:
No
Rx
Yes
Reimbursement:
No
Product Code:
SA16909
Trade Name:
Avacyn
Dosage/Volume:
400mg / 250 ml
Pharmaceutical Form:
Solution for infusion
Active Substance:
Moxifloksacin
Package:
Box x Glass bottle x 250 ml
Solution for infusion - 400 mg/250 ml
Solution for infusion - 400 mg/250 ml
Home
About Us
Products
Operations
News & Media
Our Caring
Digital Address
Overview
Product Categories
Manufacturing
News & Events
Protect our People
Get In Touch
Company Profile
New Products
Logistics
Multimedia Gallery
Our Giving
Leadership
Product Development
New Investments
Publications
Company Initiatives
History
Calendar
